Were Robert Malone's DOMANE results communicated to China?

Robert Malone has been criticized for his role in using DOMANE. Malone recently wrote that he had been accused of suppressing Ivermectin and bringing about the authorization of Remdesivir by using DOMANE. Not only that, but that he had been accused of having some sort of role in the 2001 Anthrax attacks and 9/11.

Among these allegations, the only one that I believe is true is the suppression of Ivermectin. There is very strong evidence that Malone actively suppressed the use Ivermectin as an anti-viral therapy for COVID. I will report that evidence in a future article.

As for DOMANE, how the system worked is a mystery. There is little to go on with DOMANE except for the words of Dr. Malone himself. There is another source of information which may shed some light on the DOMANE system and how it was used, however, which I will briefly review here.

Chinese authors published an article in February 2020 about computer modeling that identified Famotidine as a treatment for COVID. The computer modeling method seems very similar to the limited information on the computer modeling methods of DOMANE which Malone has provided. The Chinese paper may even be referring to the DOMANE system results. That is speculation. There is reason to believe so however.

The Chinese paper is titled: “Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.”

The paper was received by China’s Acta Pharmaceutica Sinica B journal on February 12, 2020 and accepted on February 18, 2020. The authors were Wu, Liu, Yang, Zhang, Zhong, Wang, Wang, Xu, Li, Li, Zheng, Chen and Li. The authors were associated with the following institutions in China:

Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

The paper identified 4 methods by which compounds could have benefit against the alleged SARS2 virus.

The therapies that act on the coronavirus can be divided into several categories based on the specific pathways: (1) some acting on enzymes or functional proteins that are critical to virus, preventing the virus RNA synthesis and replication; (2) some acting on structural proteins of virus, blocking virus from binding to human cell receptors, or inhibiting the virus's self-assembly process; (3) some producing virulence factor to restore host's innate immunity; (4) some acting on host's specific receptors or enzymes, preventing virus from entering into host's cells.

As for whether Remdesivir might qualify as something that would be identified in the vaguely-identified computer modeling, I suppose Remdesivir might qualify in the #1 category: “preventing the virus synthesis and replication.” A Canadian paper on Remdesivir called Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency mentions similar language on preventing RNA synthesis with Remdesivir.

I use the term “alleged” when referring to the SARS-CoV-2 sequence because the authenticity of the genetic sequence was not independently confirmed by the United States. China uploaded the sequence to the internet on January 10, 2020. BARDA Director Rick Bright reported in a whistleblower complaint that his efforts to obtain virus samples from China and confirm genetic sequencing were denied. From vaccines to Remdesivir, to all the compounds in between, and all the ones that were rejected despite numerous doctors reporting their success stories in the field, the entire response of the United States to SARS2 was based on taking China’s word for it.

In any case, Famotidine was one of the compounds identified in the February 12, 2020 Chinese paper.

Malone has said several times that DOMANE identified Famotidine and Celecoxib for SARS2. Malone later published in Hospitalized COVID-19 Patients Treated With Celecoxib and High Dose Famotidine Adjuvant Therapy Show Significant Clinical Responses. that “HD famotidine acts to reduce cellular effects of local histamine via H2 receptor antagonism.” I don’t understand how DOMANE would have picked up that method of action. I don’t know if that method of action would somehow have been identified by the methods reported in the Chinese paper, but it was identified by both nonetheless.

The computer model reported by China analyzed the following compounds:

Approved drug database was from the subset of ZINC database, ZDD (ZINC drug database) containing 2924 compounds²². Natural products database was constructed by ourselves, containing 1066 chemicals separated from traditional Chinese herbals in own laboratory and naturally occurring potential anti-viral components and derivatives.

So China reported that they analyzed compounds from the ZINC database and their own Chinese herbal remedies. This is very similar, I believe, to what Robert Malone would have done with DOMANE. He had the Chinese herbal protocols.

Robert Malone told Joe Rogan on December 30, 2021 that: "I was the guy that first acquired, because I had Chinese connections, the Chinese protocol for treating this virus. I got it in late February and I sent it in to my buddies at the CIA and at DTRA."

So Malone had the Chinese herbal based protocols that the Chinese authors reported in the Chinese paper on computer modeling. As for the ZINC database, it is based in the University of California- San Fransisco. The Chinese paper references ZINC: A Free Tool to Discover Chemistry for Biology which in turn references the database location in California- San Fransisco.

Dr. Malone’s education includes the University of California at Davis and San Diego. In addition to the Chinese herbal protocols which he received, it seems very likely that Malone would include the ZINC database in DOMANE. The point is that the computer modeling methods and database that was analyzed as reported in the Chinese paper sound very similar to DOMANE, although again that is speculation.

The Chinese paper makes a reference to some software based in San Diego. I don’t know if DOMANE used this software or not. DOMANE appears to be a classified system. Malone holds a “secret” clearance with the DoD, according to his CV.

Dr. Michael Callahan, a CIA agent as described by Dr. Malone, came back to the United States and reported COVID mortality rates among people receiving Famotidine and Omeprazole. Callahan reported the “COVID” death rate in the presence of Famotidine at 14%, but 27% in the presence of Omeprazole. From this information Dr. Callahan claimed that Famotidine was a successful treatment for COVID. Callahan went to Robert Kadlec, ASPR, and requested a study to prove the effectiveness of Famotidine. Kadlec contracted with Alchem for the study. Malone designed the study. Malone resigned after the “standard of care” used in the study was changed from Hydroxychloroquine to Remdesivir. The use of Remdesivir and Ventilators gave “researchers” the ability to control death rates between the test and control groups in the clinical trials of Famotidine which were subcontracted to Northwell.

Various media reports claim that Dr. Malone and Dr. Callahan came across their information on Famotidine independently of each other. This, despite the facts that the two had worked on research on two other Pandemics, Ebola and Zika; despite the fact that Malone and Callahan had co-authored papers on Zika, and despite Dr. Callahan calling Dr. Malone from “outside Wuhan” on January 4, 2020 and telling him to get his team at Alchem (which had the DOMANE) system to work.

Just assuming the unlikely case that Malone and Callahan observed some strict communication protocols and did not communicate with each other about Famotidine after Malone “discovered” it in DOMANE, despite their common research on other Pandemics, and their communications between China and the United States, it is entirely possible that Malone could have communicated his DOMANE results to his colleagues in China, who had graciously shared their herbal protocols with Malone. China could have then implemented tests involving Famotidine, which Dr. Callahan supervised, but did not directly communicate with Malone on. Or China could have had a system that paralleled DOMANE somehow.

In any case, these are questions that the public deserves to know the answer to. The origins of the Pandemic are as follows: The CIA perfected hospital death protocols in China in order to create the appearance of a deadly and rapidly spreading genetically engineered virus. They may have had a virus sequence at some point; or they may not have. Their methods obviously involved death by Remdesivir, Ventilators, and related protocols, a method which was exported to the United States.

If this was not the case, why then would there be so much censorship on Famotidine? LinkedIn, the New York Times, and Robert Malone have all removed articles and information on Malone’s discovery of Famotidine. It is because Famotidine is a window into the role of the United States in the early stages of the staged Pandemic in China.

So I urge Dr. Malone, the self-described “whistleblower,” to report the nature of his complete communications with Dr. Callahan and China from around December 2019 to March 2021. The public deserves to have this information. By withholding this information, Dr. Malone is not a whistleblower; he is an accomplice to the Plandemic.

Charles Wright